Search

Jehanne Souaya Sitton

Examiner (ID: 17461, Phone: (571)272-0752 , Office: P/1634 )

Most Active Art Unit
1634
Art Unit(s)
1634, 1682, 1655
Total Applications
1479
Issued Applications
528
Pending Applications
307
Abandoned Applications
653

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 13537375 [patent_doc_number] => 20180320234 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-11-08 [patent_title] => BIOMARKERS FOR ASSESSING IDIOPATHIC PULMONARY FIBROSIS [patent_app_type] => utility [patent_app_number] => 16/031384 [patent_app_country] => US [patent_app_date] => 2018-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9553 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16031384 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/031384
Biomarkers for assessing idiopathic pulmonary fibrosis Jul 9, 2018 Issued
Array ( [id] => 17060375 [patent_doc_number] => 11104965 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-08-31 [patent_title] => Methods for the diagnosis and treatment of inflammatory bowel disease [patent_app_type] => utility [patent_app_number] => 16/028937 [patent_app_country] => US [patent_app_date] => 2018-07-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 40 [patent_figures_cnt] => 45 [patent_no_of_words] => 41513 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16028937 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/028937
Methods for the diagnosis and treatment of inflammatory bowel disease Jul 5, 2018 Issued
Array ( [id] => 16157365 [patent_doc_number] => 20200216915 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-07-09 [patent_title] => METHOD FOR DETECTING PARASITIC INFECTION AND KIT [patent_app_type] => utility [patent_app_number] => 16/628259 [patent_app_country] => US [patent_app_date] => 2018-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9178 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16628259 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/628259
Method for detecting parasitic infection and kit Jun 27, 2018 Issued
Array ( [id] => 13479845 [patent_doc_number] => 20180291465 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-10-11 [patent_title] => MATERIALS AND METHODS FOR ASSESSMENT OF COLORECTAL ADENOMA [patent_app_type] => utility [patent_app_number] => 16/005207 [patent_app_country] => US [patent_app_date] => 2018-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15470 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -3 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16005207 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/005207
MATERIALS AND METHODS FOR ASSESSMENT OF COLORECTAL ADENOMA Jun 10, 2018 Abandoned
Array ( [id] => 16642435 [patent_doc_number] => 10920276 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-02-16 [patent_title] => Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof [patent_app_type] => utility [patent_app_number] => 15/991247 [patent_app_country] => US [patent_app_date] => 2018-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 69791 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15991247 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/991247
Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof May 28, 2018 Issued
Array ( [id] => 13552633 [patent_doc_number] => 20180327864 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-11-15 [patent_title] => C-CBL MUTATIONS AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 15/990301 [patent_app_country] => US [patent_app_date] => 2018-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28063 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15990301 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/990301
C-CBL mutations and uses thereof May 24, 2018 Issued
Array ( [id] => 13552631 [patent_doc_number] => 20180327863 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-11-15 [patent_title] => ARID1A AND PPP2R1A MUTATIONS IN CANCER [patent_app_type] => utility [patent_app_number] => 15/987235 [patent_app_country] => US [patent_app_date] => 2018-05-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19228 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15987235 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/987235
ARID1A AND PPP2R1A MUTATIONS IN CANCER May 22, 2018 Abandoned
Array ( [id] => 18748607 [patent_doc_number] => 11807906 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2023-11-07 [patent_title] => Peroxisome biomarkers in HIV disease progression and peroxisome activating drugs for HIV treatment [patent_app_type] => utility [patent_app_number] => 16/606665 [patent_app_country] => US [patent_app_date] => 2018-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 23 [patent_no_of_words] => 21237 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16606665 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/606665
Peroxisome biomarkers in HIV disease progression and peroxisome activating drugs for HIV treatment May 6, 2018 Issued
Array ( [id] => 19274430 [patent_doc_number] => 12024541 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-07-02 [patent_title] => Transmembrane pore consisting of two CsgG pores [patent_app_type] => utility [patent_app_number] => 16/610895 [patent_app_country] => US [patent_app_date] => 2018-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 23 [patent_no_of_words] => 42519 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16610895 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/610895
Transmembrane pore consisting of two CsgG pores May 2, 2018 Issued
Array ( [id] => 19274430 [patent_doc_number] => 12024541 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-07-02 [patent_title] => Transmembrane pore consisting of two CsgG pores [patent_app_type] => utility [patent_app_number] => 16/610895 [patent_app_country] => US [patent_app_date] => 2018-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 23 [patent_no_of_words] => 42519 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16610895 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/610895
Transmembrane pore consisting of two CsgG pores May 2, 2018 Issued
Array ( [id] => 14019461 [patent_doc_number] => 20190071724 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-03-07 [patent_title] => DIAGNOSTIC METHODS [patent_app_type] => utility [patent_app_number] => 15/966905 [patent_app_country] => US [patent_app_date] => 2018-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13754 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15966905 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/966905
DIAGNOSTIC METHODS Apr 29, 2018 Abandoned
Array ( [id] => 15832589 [patent_doc_number] => 20200131576 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-04-30 [patent_title] => IL-8, IL-6, IL-1 Beta and TET2 and DNMT3A in Atherosclerosis [patent_app_type] => utility [patent_app_number] => 16/606928 [patent_app_country] => US [patent_app_date] => 2018-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28675 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16606928 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/606928
IL-8, IL-6, IL-1 Beta and TET2 and DNMT3A in Atherosclerosis Apr 23, 2018 Abandoned
Array ( [id] => 13372633 [patent_doc_number] => 20180237857 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-08-23 [patent_title] => METHOD OF PREDICTING A PREDISPOSITION TO QT PROLONGATION [patent_app_type] => utility [patent_app_number] => 15/956052 [patent_app_country] => US [patent_app_date] => 2018-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3935 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 147 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15956052 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/956052
Method of predicting a predisposition to QT prolongation Apr 17, 2018 Issued
Array ( [id] => 15590477 [patent_doc_number] => 20200071773 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-03-05 [patent_title] => TUMOR SIGNATURE FOR METASTASIS, COMPOSITIONS OF MATTER METHODS OF USE THEREOF [patent_app_type] => utility [patent_app_number] => 16/604651 [patent_app_country] => US [patent_app_date] => 2018-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 88311 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16604651 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/604651
TUMOR SIGNATURE FOR METASTASIS, COMPOSITIONS OF MATTER METHODS OF USE THEREOF Apr 11, 2018 Pending
Array ( [id] => 15024117 [patent_doc_number] => 20190323063 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-24 [patent_title] => COMPOSITIONS AND METHODS FOR DETECTION OF MYCOBACTERIUM TUBERCULOSIS [patent_app_type] => utility [patent_app_number] => 15/952133 [patent_app_country] => US [patent_app_date] => 2018-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8853 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15952133 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/952133
Compositions and methods for detection of Apr 11, 2018 Issued
Array ( [id] => 13493773 [patent_doc_number] => 20180298429 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-10-18 [patent_title] => BIOCHIPS AND RAPID METHODS FOR DETECTING ORGANISMS INVOLVED IN MICROBIALLY INFLUENCED CORROSION (MIC) [patent_app_type] => utility [patent_app_number] => 15/949400 [patent_app_country] => US [patent_app_date] => 2018-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20415 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -33 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15949400 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/949400
Biochips and rapid methods for detecting organisms involved in microbially influenced corrosion (MIC) Apr 9, 2018 Issued
Array ( [id] => 13358007 [patent_doc_number] => 20180230543 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-08-16 [patent_title] => VARIANTS OF TNFSF15 AND DCR3 ASSOCIATED WITH CROHN'S DISEASE [patent_app_type] => utility [patent_app_number] => 15/946632 [patent_app_country] => US [patent_app_date] => 2018-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6816 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15946632 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/946632
VARIANTS OF TNFSF15 AND DCR3 ASSOCIATED WITH CROHN'S DISEASE Apr 4, 2018 Abandoned
Array ( [id] => 13343649 [patent_doc_number] => 20180223364 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-08-09 [patent_title] => TREATING FEMALE PELVIC ORGAN PROLAPSE [patent_app_type] => utility [patent_app_number] => 15/944212 [patent_app_country] => US [patent_app_date] => 2018-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9242 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 144 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15944212 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/944212
TREATING FEMALE PELVIC ORGAN PROLAPSE Apr 2, 2018 Abandoned
Array ( [id] => 18996242 [patent_doc_number] => 11913075 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-02-27 [patent_title] => Methods and compositions for detecting and modulating an immunotherapy resistance gene signature in cancer [patent_app_type] => utility [patent_app_number] => 16/499908 [patent_app_country] => US [patent_app_date] => 2018-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 108 [patent_figures_cnt] => 108 [patent_no_of_words] => 106158 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 146 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16499908 [rel_patent_id] =>[rel_patent_doc_number] =>)
16/499908
Methods and compositions for detecting and modulating an immunotherapy resistance gene signature in cancer Mar 29, 2018 Issued
Array ( [id] => 13314921 [patent_doc_number] => 20180208997 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-07-26 [patent_title] => METHODS, COMPOSITIONS, AND DEVICES UTILIZING MicroRNA TO DETERMINE PHYSIOLOGICAL CONDITIONS [patent_app_type] => utility [patent_app_number] => 15/926861 [patent_app_country] => US [patent_app_date] => 2018-03-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14864 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15926861 [rel_patent_id] =>[rel_patent_doc_number] =>)
15/926861
METHODS, COMPOSITIONS, AND DEVICES UTILIZING MicroRNA TO DETERMINE PHYSIOLOGICAL CONDITIONS Mar 19, 2018 Abandoned
Menu